Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Same name, different drugs: variability of fentanyl (‘dope’) products sold under the same label
HTML
Details
Locations
Year:
2026
Type:
article
Source:
International Journal of Drug Policy
DOI:
10.1016/j.drugpo.2026.105476
Authors:
Karli R. Hochstatter,
Talia Nadel,
Jan Gryczynski,
Brent Waninger,
Dalton Clouse,
Edward Schiavi,
Jaclyn Black,
Edward Sisco,
Meghan G. Appley,
Elise M. Pyfrom,
Margaret Rybak,
Janelle Hodgson,
Sarah Laurel,
Fernando Montero
show all 14
Institutions:
Friends Research Institute,
CDC Foundation,
National Institute of Standards and Technology,
Maryland Department of Health,
Columbia University
Language:
English
Topic:
Opioid Use Disorder Treatment
Subfield:
Public Health, Environmental and Occupational Health
Field:
Medicine
Domain:
Health Sciences
Keywords:
fentanyl,
drug adulterants,
medetomidine,
xylazine,
drug checking,
harm reduction,
drug composition,
Philadelphia,
Delaware,
Maryland
show all 10
SDG:
Good health and well-being
Open Access status:
closed
Funder:
National Center for Injury Prevention and Control
OpenAlex ID:
W7204490702
FWCI:
Cites:
24
Cited by:
Related to:
9